https://www.selleckchem.com/pr....oducts/nivolumab.htm
on or individualized therapy may provide potential survival benefits. This study aimed to develop radiomic models based on low-dose CT (LDCT) and standard-dose CT to distinguish adenocarcinomas from benign lesions in patients with solid solitary pulmonary nodules and compare the performance among these radiomic models and Lung CT Screening Reporting and Data System (Lung-RADS). The reproducibility of radiomic features between LDCT and standard-dose CT were also evaluated. A total of 141 consecutive pathologically confirmed solid solit
Like
Comment
Share
